【Neuronetics Inc(STIM)投资者维权信息】
2021年10月12日Neuronetics Inc(STIM)公布了初步收入结果,预计第三季度的总收入约为 1380 万美元,而此前发布的指导为 1500 万美元至 1600 万美元。公司还下调了全年收入指引,预计 2021 财年在 5,330 万美元至 5,430 万美...查看全文
蹊之美股生物医药2021-08-04 23:10
作者:林出
微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
Arcturus Therapeutics (NASDAQ:ARCT) +68%
Flora Growth (NASDAQ:FLGC) +62%
Translate Bio (NASDAQ:TBIO) +29%
Outlook Therapeutics (NASDAQ:OTLK) +6%
Losers:
Neuronet...查看全文
$Neuronetics(STIM)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2019-02-14 AccNo: 0000905718-19-000225 Size: 40 KB 网页链接
$Neuronetics(STIM)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2019-02-14 AccNo: 0001193125-19-039666 Size: 47 KB 网页链接
$Neuronetics(STIM)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2019-02-13 AccNo: 0001193125-19-038100 Size: 136 KB 网页链接
$Neuronetics(STIM)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2019-02-06 AccNo: 0001140361-19-002598 Size: 112 KB 网页链接
$Neuronetics(STIM)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2019-01-29 AccNo: 0001104659-19-004060 Size: 156 KB 网页链接
$Neuronetics(STIM)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2019-01-29 AccNo: 0001104659-19-004060 Size: 156 KB 网页链接
$Neuronetics(STIM)$ 8-K - Current report Filed: 2019-01-07 AccNo: 0001564590-19-000280 Size: 66 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Neuronetics, Inc.(STIM)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-11-06 AccNo: 0001564590-18-027435 Size: 7 MB 网页链接
$Neuronetics, Inc.(STIM)$ 8-K - Current report Filed: 2018-11-06 AccNo: 0001564590-18-027078 Size: 512 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Neuronetics, Inc.(STIM)$ 美东时间 2018-11-06 盘前 披露财报,预期EPS -0.4 网页链接